Beth Israel Deaconess Medical Center Inc is categorized under Substance Abuse Clinics (Outpatient) in New York City, NY .
Beth Israel Deaconess Medical Center Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Substance Abuse Clinics (Outpatient) business, which does work in the B2C market, and is classified as a Substance Abuse Clinics (Outpatient), under code number 621498 by the NAICS.
If you are seeking more information, feel free to contact at the company’s branch by writing to 1825 Park Avenue Floor 8, New York City, New York NY 10035 or by phoning (212) 774-3210. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Beth Israel Deaconess Medical Center Inc |
Address: | 1825 Park Avenue Floor 8, New York City, New York 10035 |
Phone Number: | (212) 774-3210 |
Website Address: | bidmc.org |
Annual Revenue (USD): | Unknown |
Location Type: | Branch |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Substance Abuse Clinics (Outpatient) |
SIC Code: | 8093 |
NAICS Code: | 621498 |
Share This Business: |
Beth Israel Deaconess Medical Center Inc was started in 0 to provide professional Substance Abuse Clinics (Outpatient) under the SIC code 8093 and NAICS code 621498. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact for inquiries that concern Beth Israel Deaconess Medical Center Inc by calling the company number (212) 774-3210, as your correspondence is most welcome. Additionally, the physical location of the branch of Beth Israel Deaconess Medical Center Inc can be found at the coordinates 40.804814,-73.938841 as well as the street address 1825 Park Avenue Floor 8 in New York City, New York 10035.
For its online presence, you may visit Beth Israel Deaconess Medical Center Inc’s website at bidmc.org and engage with its social media outlets through on Twitter and on Facebook.